RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK)
Germany · Delayed Price · Currency is EUR 14.40
-0.10 (-0.69%)
Oct 19, 2026, 5:35 PM CET
ETR:RHK Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 964 | 850 | 930 | 669 | 1,024 | 963 | |
Market Cap Growth | 22.03% | -8.63% | 39.00% | -34.64% | 6.40% | -12.85% |
Enterprise Value | 803 | 800 | 804 | 694 | 819 | 999 |
Last Close Price | 14.50 | 12.50 | 13.57 | 9.76 | 14.76 | 13.87 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 23.06 | 24.66 | 21.46 | 17.29 | 40.73 | 34.02 |
Forward PE | 22.66 | 17.13 | 21.72 | 39.33 | 50.58 | 22.92 |
PS Ratio | 0.48 | 0.43 | 0.50 | 0.39 | 0.62 | 0.61 |
PB Ratio | 0.71 | 0.63 | 0.70 | 0.52 | 0.82 | 0.79 |
P/TBV Ratio | 0.84 | 0.74 | 0.83 | 0.62 | 0.98 | 0.95 |
P/FCF Ratio | 77.65 | - | 16.27 | 14.49 | 487.70 | 48.86 |
P/OCF Ratio | 7.64 | 14.86 | 7.29 | 6.14 | 16.98 | 9.87 |
PEG Ratio | - | 7.87 | 7.87 | 7.87 | 41.32 | 41.32 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.40 | 0.41 | 0.43 | 0.40 | 0.49 | 0.63 |
EV/EBITDA Ratio | 7.04 | 7.92 | 7.55 | 6.84 | 8.39 | 10.54 |
EV/EBIT Ratio | 14.77 | 18.04 | 17.05 | 17.81 | 26.15 | 36.06 |
EV/FCF Ratio | 64.81 | - | 14.06 | 15.03 | 389.94 | 50.74 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.09 | 0.09 | 0.11 | 0.12 | 0.13 | 0.13 |
Debt / EBITDA Ratio | 1.06 | 1.17 | 1.36 | 1.43 | 1.57 | 1.63 |
Debt / FCF Ratio | 9.75 | - | 2.62 | 3.24 | 75.31 | 8.11 |
Net Debt / Equity Ratio | -0.14 | -0.15 | -0.20 | -0.15 | -0.11 | -0.11 |
Net Debt / EBITDA Ratio | -1.71 | -2.06 | -2.44 | -1.90 | -1.42 | -1.40 |
Net Debt / FCF Ratio | -15.27 | 4.96 | -4.54 | -4.18 | -65.81 | -6.72 |
Asset Turnover | 1.10 | 1.07 | 1.03 | 1.00 | 0.99 | 0.97 |
Inventory Turnover | 45.54 | 45.40 | 46.27 | 45.37 | 43.87 | 41.21 |
Quick Ratio | 2.36 | 2.41 | 2.08 | 2.19 | 2.20 | 2.09 |
Current Ratio | 2.63 | 2.61 | 2.23 | 2.35 | 2.37 | 2.24 |
Return on Equity (ROE) | 3.28% | 2.71% | 3.47% | 3.17% | 2.18% | 2.50% |
Return on Assets (ROA) | 1.85% | 1.51% | 1.63% | 1.40% | 1.16% | 1.05% |
Return on Invested Capital (ROIC) | 3.53% | 3.24% | 3.52% | 2.98% | 2.27% | 2.54% |
Return on Capital Employed (ROCE) | 3.70% | 3.00% | 3.20% | 2.70% | 2.20% | 2.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.34% | 4.06% | 4.66% | 5.78% | 2.46% | 2.94% |
FCF Yield | 1.29% | -4.93% | 6.15% | 6.90% | 0.21% | 2.05% |
Dividend Yield | 1.39% | 1.57% | 0.72% | - | 0.98% | - |
Payout Ratio | 31.84% | 19.44% | - | 25.83% | - | - |
Total Shareholder Return | 1.40% | 1.57% | 0.72% | - | 0.98% | - |